DAWN vs AMGN: Which Stock is Better?
Side-by-side comparison of Day One Biopharmaceuticals Inc and Amgen Inc in 2026
DAWN
Day One Biopharmaceuticals Inc
$21.20
AMGN
Amgen Inc
$369.53
Key Metrics Comparison
| Metric | DAWN | AMGN | Winner |
|---|---|---|---|
| Market Cap | $1.32B | $199.20B | AMGN |
| P/E Ratio | N/A | 25.84 | AMGN |
| EPS (TTM) | $N/A | $14.30 | AMGN |
| Revenue Growth | 0.8% | 0.1% | DAWN |
| Gross Margin | 89.1% | 70.8% | DAWN |
Analyze DAWN
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is DAWN or AMGN a better investment?
Comparing DAWN and AMGN: Day One Biopharmaceuticals Inc has a market cap of $1.32B while Amgen Inc has $199.20B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between DAWN and AMGN?
DAWN (Day One Biopharmaceuticals Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: DAWN or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: DAWN or AMGN?
DAWN has higher revenue growth at 0.8% vs 0.1% for AMGN.
Which company is more profitable: DAWN or AMGN?
Day One Biopharmaceuticals Inc (DAWN) has higher gross margins at 89.1% compared to 70.8% for AMGN.
Which is the larger company: DAWN or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $199.20B compared to $1.32B for DAWN.
Should I buy DAWN or AMGN in 2026?
Both DAWN and AMGN have investment merit. DAWN trades at $21.20 while AMGN trades at $369.53. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between DAWN and AMGN stock?
Key differences: Market Cap ($1.32B vs $199.20B), P/E Ratio (N/A vs 25.8x), Revenue Growth (0.8% vs 0.1%), Gross Margin (89.1% vs 70.8%).